Treatment for glioblastoma multiforme: Current guidelines and Canadian practice

Current Oncology

Volumn 17, Issue 6, 2010, Pages 52-58

  Ghose, A ^a   Lim, G ^a   Husain, S ^a  

^a TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Canadian; Glioblastoma multiforme; Margins; Radiation; Survey; Treatment; Volumes

Indexed keywords

BROXURIDINE;

ARTICLE; CANADA; CANCER GRADING; CANCER SIZE; CANCER SURGERY; CLINICAL PROTOCOL; COMPUTER ASSISTED RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; HEALTH CARE SURVEY; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING;

EID: 78650141643     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v17i6.574     Document Type: Article

References (16)

1. Perez C, Brady L, Halperin E, Schmidt-Ullrich R, eds. Principles and Practice of Radiation Oncology. Philadelphia: Lip-pincott Williams and Wilkins; 2004.
2. Kleihues P, Cavenee WK, eds. World Health Organization Classifcation of Tumors: Pathology and Genetics of Tumors of the Nervous System. Lyon, France: ia r c Press; 2000.
3. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-1329.
4. Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade iii and iv. Confrmation of the value of postoperative irradiation and lack of potentia-tion of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-52.
5. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
6. Colman H, Berkey BA, Maor MH, et al. Phase ii Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of rto g 9710. Int J Radiat Oncol Biol Phys 2006;66:818-24.
7. Mason WP, Maestro RD, Eisenstat D, et al. Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 2007;14:110-17.
8. Wallner KE, Galicich JH, Krol G, et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989;16:1405-9.
9. Liang BC, Thornton AF, Sandler HM, Greenberg HS. Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 1991;75:559-63.
10. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M. 3-D-recurrence-patterns of glioblastomas after ct -planned postoperative irradiation. Radiother Oncol 1999;53:53-7.
11. Chang EL, Akyurek S, Avalos T, et al. Evaluation of peritu-moral edema in the delineation of clinical target volumes for glioblastoma. Int J Radiat Oncol Bio Phys 2007;68:144-50.
12. McDonald MW, Shu HG, Curran WJ, Crocker IR. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma [abstract]. Int J Radiat Oncol Biol Phys 2009;75(suppl 1):S227.
13. Gonzalez-Gonzalez D, Menten J, Bosch DA, et al. Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 1994;32:98-105.
14. Cardinale R, Won M, Choucair A, et al. A phase ii trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: rto g 0023. Int J Radiat Oncol Biol Phys 2006;65:1422-8.
15. Sultanem K, Patrocinio H, Lambert C, et al. The use of hypof-ractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 2004;58:247-52.
16. Tsien C, Moughan J, Michalski JM, et al. Phase i three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03. Int J Radiat Oncol Biol Phys 2009;73:699-708.